The company's third-quarter revenue jumped 49% year over year to hit $599 million, and the company brought in net income of nearly $15.8 million
During that time, I lost my hair, my muscle mass, and even part of my vision
The concept of dose stepping, using a higher dose for initial weight loss and then transitioning to a lower dose for maintenance, could become the standard treatment paradigm if the data supports it
Yes, they can cause side effects from skin irritation or issues with adhesives
Here we report the engineering and preclinical development of a bimodal molecule that integrates NMDA receptor antagonism with glucagon-like peptide-1 (GLP-1) receptor agonism to effectively reverse obesity, hyperglycaemia and dyslipidaemia in rodent models of metabolic disease
That's accurate as far as it goes